Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Chopra

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry|February 19, 2009
Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screeningSamo Turk, Andreja Kovac, Audrey Boniface, et al.
Journal of Medicinal Chemistry|December 5, 2008
Discovery of new inhibitors of D-alanine:D-alanine ligase by structure-based virtual screeningAndreja Kovac, Janez Konc, Blaz Vehar, et al.
The Journal of Antimicrobial Chemotherapy|February 22, 2005
Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175)Keith Miller, Christopher Storey, William J Stubbings, et al.
Antimicrobial Agents and Chemotherapy|February 16, 2011
Activity of and development of resistance to corallopyronin A, an inhibitor of RNA polymeraseKatherine Mariner, Martin McPhillie, Rachel Trowbridge, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2007
Diazenedicarboxamides as inhibitors of D-alanine-D-alanine ligase (Ddl)Andreja Kovac, Vita Majce, Roman Lenarsic, et al.
Bioorganic & Medicinal Chemistry|August 12, 2011
Ellipticines and 9-acridinylamines as inhibitors of D-alanine:D-alanine ligaseBlaž Vehar, Martina Hrast, Andreja Kovač, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2010
Furanyl-rhodanines are unattractive drug candidates for development as inhibitors of bacterial RNA polymeraseKatherine R Mariner, Rachel Trowbridge, Anil K Agarwal, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Biological properties of novel antistaphylococcal quinoline-indole agentsBrunello Oliva, Keith Miller, Nico Caggiano, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure-based ligand design of novel bacterial RNA polymerase inhibitorsMartin J McPhillie, Rachel Trowbridge, Katherine R Mariner, et al.
The Lancet. Infectious Diseases|January 29, 2008
Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statementIan Chopra, Christopher Schofield, Martin Everett, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry|February 19, 2009
Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screeningSamo Turk, Andreja Kovac, Audrey Boniface, et al.
Journal of Medicinal Chemistry|December 5, 2008
Discovery of new inhibitors of D-alanine:D-alanine ligase by structure-based virtual screeningAndreja Kovac, Janez Konc, Blaz Vehar, et al.
The Journal of Antimicrobial Chemotherapy|February 22, 2005
Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175)Keith Miller, Christopher Storey, William J Stubbings, et al.
Antimicrobial Agents and Chemotherapy|February 16, 2011
Activity of and development of resistance to corallopyronin A, an inhibitor of RNA polymeraseKatherine Mariner, Martin McPhillie, Rachel Trowbridge, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2007
Diazenedicarboxamides as inhibitors of D-alanine-D-alanine ligase (Ddl)Andreja Kovac, Vita Majce, Roman Lenarsic, et al.
Bioorganic & Medicinal Chemistry|August 12, 2011
Ellipticines and 9-acridinylamines as inhibitors of D-alanine:D-alanine ligaseBlaž Vehar, Martina Hrast, Andreja Kovač, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2010
Furanyl-rhodanines are unattractive drug candidates for development as inhibitors of bacterial RNA polymeraseKatherine R Mariner, Rachel Trowbridge, Anil K Agarwal, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Biological properties of novel antistaphylococcal quinoline-indole agentsBrunello Oliva, Keith Miller, Nico Caggiano, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure-based ligand design of novel bacterial RNA polymerase inhibitorsMartin J McPhillie, Rachel Trowbridge, Katherine R Mariner, et al.
The Lancet. Infectious Diseases|January 29, 2008
Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statementIan Chopra, Christopher Schofield, Martin Everett, et al.
Pageof 6